Viewing Study NCT04419467


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-02-23 @ 11:17 AM
Study NCT ID: NCT04419467
Status: COMPLETED
Last Update Posted: 2023-12-06
First Post: 2020-06-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease
Sponsor: CSL Behring
Organization: